Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Imaging Neuroinflammation In Vivo in a Neuropathic Pain Rat Model with Near-Infrared Fluorescence and 19F Magnetic Resonance

  • Kiran Vasudeva,

    Affiliation Biological Sciences, Bayer School of Natural and Environmental Sciences, and Chronic Pain Research Consortium, Duquesne University, Pittsburgh, Pennsylvania, United States of America

  • Karl Andersen,

    Affiliation Biological Sciences, Bayer School of Natural and Environmental Sciences, and Chronic Pain Research Consortium, Duquesne University, Pittsburgh, Pennsylvania, United States of America

  • Bree Zeyzus-Johns,

    Affiliation Biological Sciences, Bayer School of Natural and Environmental Sciences, and Chronic Pain Research Consortium, Duquesne University, Pittsburgh, Pennsylvania, United States of America

  • T. Kevin Hitchens,

    Affiliation NMR Center for Biomedical Research, Carnegie Mellon University, Pittsburgh, Pennsylvania, United States of America

  • Sravan Kumar Patel,

    Affiliation Graduate School of Pharmaceutical Sciences, Mylan School of Pharmacy, and Chronic Pain Research Consortium, Duquesne University, Pittsburgh, Pennsylvania, United States of America

  • Anthony Balducci,

    Affiliation Department of Research and Development, Celsense, Inc., Pittsburgh, Pennsylvania, Unite States of America

  • Jelena M. Janjic,

    Affiliation Graduate School of Pharmaceutical Sciences, Mylan School of Pharmacy, and Chronic Pain Research Consortium, Duquesne University, Pittsburgh, Pennsylvania, United States of America

  • John A. Pollock

    Affiliation Biological Sciences, Bayer School of Natural and Environmental Sciences, and Chronic Pain Research Consortium, Duquesne University, Pittsburgh, Pennsylvania, United States of America

Imaging Neuroinflammation In Vivo in a Neuropathic Pain Rat Model with Near-Infrared Fluorescence and 19F Magnetic Resonance

  • Kiran Vasudeva, 
  • Karl Andersen, 
  • Bree Zeyzus-Johns, 
  • T. Kevin Hitchens, 
  • Sravan Kumar Patel, 
  • Anthony Balducci, 
  • Jelena M. Janjic, 
  • John A. Pollock


Chronic neuropathic pain following surgery represents a serious worldwide health problem leading to life-long treatment and the possibility of significant disability. In this study, neuropathic pain was modeled using the chronic constriction injury (CCI). The CCI rats exhibit mechanical hypersensitivity (typical neuropathic pain symptom) to mechanical stimulation of the affected paw 11 days post surgery, at a time when sham surgery animals do not exhibit hypersensitivity. Following a similar time course, TRPV1 gene expression appears to rise with the hypersensitivity to mechanical stimulation. Recent studies have shown that immune cells play a role in the development of neuropathic pain. To further explore the relationship between neuropathic pain and immune cells, we hypothesize that the infiltration of immune cells into the affected sciatic nerve can be monitored in vivo by molecular imaging. To test this hypothesis, an intravenous injection of a novel perfluorocarbon (PFC) nanoemulsion, which is phagocytosed by inflammatory cells (e.g. monocytes and macrophages), was used in a rat CCI model. The nanoemulsion carries two distinct imaging agents, a near-infrared (NIR) lipophilic fluorescence reporter (DiR) and a 19F MRI (magnetic resonance imaging) tracer, PFC. We demonstrate that in live rats, NIR fluorescence is concentrated in the area of the affected sciatic nerve. Furthermore, the 19F MRI signal was observed on the sciatic nerve. Histological examination of the CCI sciatic nerve reveals significant infiltration of CD68 positive macrophages. These results demonstrate that the infiltration of immune cells into the sciatic nerve can be visualized in live animals using these methods.


Pain is a public health problem that has deleterious effects on social, mental, physical and economic health of its sufferers [1]. Pain caused by injury or disease associated with the somatosensory nervous system is called neuropathic pain [2]. Recent studies have estimated that at least 6 million Americans suffer from neuropathic pain [3]. Other studies indicate that neuropathic pain is usually associated with nerve inflammation [4], which occurs when leukocytes such as macrophages infiltrate the nerve. Understanding the role of key inflammatory cytokines and immune cells involved in neuropathic pain could lead to a deeper understanding of the signaling mechanisms involved in hypersensitivity as well as better diagnostic and treatment strategies.

The chronic constriction injury (CCI) rat model [5] is a well-characterized example of chronic peripheral neuropathic pain [6]. This model is widely used to simulate Complex Regional Pain Syndrome type II observed in humans (CRPS II, earlier called causalgia) [5]. CRPS II develops when a major peripheral nerve is injured [7] and includes persistent pain and mechanical allodynia [8].

Significant advances have been made in understanding the molecular basis of the diseases and conditions of chronic pain and the hypersensitivity associated with CCI. In many cases, hypersensitivity correlates with changes in the expression of specific ion channels [9]. Among these are cation channel proteins including the Transient Receptor Potential (TRP), a superfamily of receptors [10] that are known for being involved in a variety of sensory processes including nociception and pain [11], [12]. In CCI, there is evidence that seven days after the CCI surgery, TRPV1 protein, but not mRNA expression increases in the Dorsal Root Ganglia (DRG) [13], [14]. Furthermore, neuroinflammation has been associated with CCI-induced mechanical hypersentivity. Clatworthy and coworkers [15] showed that inflammation plays a key role in pathophysiology of neuropathic pain. Furthermore, macrophages have been shown to play a central role in causing the inflammation that contributes to peripheral neuropathies [16]. It has also been demonstrated that Wallerian degeneration occurs in CCI rat model [17]. During Wallerian degeneration, resident macrophages and the Schwann cells are the first cells to respond to the insult and together they initiate the axonal degeneration phase of the distal portion of the damaged nerve. Within the first three days of nerve injury, acute inflammation is evident with the infiltration of neutrophils reaching the site of injury via diapedesis [18]. The peak in neutrophil infiltration is reached within 24 hours of injury. From day 4 to day 14 post injury, hematogenous macrophages infiltrate the injured nerve area, reaching a peak around 1 week post injury [18]. One of the roles of these macrophages is to remove the degenerating nerve tissue debris and to cause inflammation [18]. The infiltration of these immune cells into damaged nerve tissue is an important component of the inflammatory process. However, the role of inflammatory cell infiltration into the site of neuronal injury and how that initiates chronic pain is not well understood. Understanding this process will ultimately lead to the development of new therapeutic agents and better pain management. To study infiltrating immune cells in a rat chronic pain model, we used a novel NIR (near-infrared) labeled perfluoro-15-crown-5 ether (PCE) nanoemulsion [19], shown to preferentially label macrophages in culture and upon intravenous administration. Perfluoropolyethers (PFPEs), including PCE, have been used for 19F MRI (magnetic resonance imaging) in multiple animal models [20], [21], [22], [23]. Specifically, PFPE nanoemulsions have become a powerful tool for imaging inflammation in varied disease models, from acute organ rejection to rheumatoid arthritis [24]. PFPE nanoemulsion droplets are taken up from the blood stream by phagocytic cells including monocytes and macrophages and carried by these cells to sites of inflammation. PFPEs in the nanoemulsions are biologically and chemically inert, and are not degraded by the phagocytic cells, which gives PFPEs advantage over other imaging modalities [25]. The 19F MR signal remains unchanged during the lifetime of the labeled cell and can be directly correlated to the immune cell number at the site of interest [26]. Further, 19F MR signal is specific for the introduced nanoemulsion and provides an unambiguous signature of monocytes and macrophages in vivo. In a recent study [19] we reported in vivo inflammation imaging demonstrating that NIR and 19F MRI can be used as complementary imaging modalities for identifying underlying cellular mechanisms in inflammation.

Previously, aspects of the role of inflammation in neuropathic pain have only been established by ex vivo techniques [27], [28], [29], [30]. To the best of our knowledge, there are no reports on visualizing neuroinflammation in live animals using the CCI model of neuropathic pain. While 19F MRI has been used previously to image in vivo neuroinflammation in the peripheral nervous system [31], we are describing for the first time a novel method to visualize the in vivo inflammation associated with nerve injury in the CCI rat. To achieve this, we are using a newly developed nanoemulsion-based dual mode imaging probe [19]. We find that NIR and 19F MRI can be used to monitor inflammation at the site of injury on the sciatic nerve. Using multiple ex vivo imaging techniques (NIR, 19F MRI and histology), we demonstrate that macrophages have infiltrated the sciatic nerve following CCI. We discuss the implication of a noninvasive assessment of neuropathic pain for use in studying pain associated with the hypersensitivity caused by CCI.

Materials and Methods

Ethics Statement

This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institute of Health, and the Institutional Animal Care and Use Committee (IACUC) at Duquesne University approved the animal protocol (Protocol 1109-10). All surgical procedures were performed under isoflurane anesthesia. Male Sprague-Dawley rats weighing 250–350 g were used in this study (Hilltop Lab Animals, Inc., Scottdale, PA). Rats were maintained on a 12∶12 hour light-dark cycle and were given ad libitum access to water and purified chow. Purified chow has been demonstrated to reduce non-specific fluorescence caused by plant materials in basic chow in the LI-COR Bioscience Application Note: In Vivo Animal Imaging Diet Consideration (

Chronic Constriction Injury

The chronic constriction injury (CCI) method developed by Bennett and Xie [5] was used to induce neuropathic pain in the sciatic nerve of rats (Figure 1A). Animals were divided into three groups; CCI, sham and naïve un-operated control. Briefly, under general anesthesia, the common sciatic nerve of the CCI animals was exposed by making an incision through the skin and carefully separating the muscles in the mid thigh region of right hind limb. Four ligatures were tied around the common sciatic nerve using 4-0 chromic gut suture. Care was taken to ensure that the ligatures were secured in place without restricting epineurial blood flow. The muscle layer was closed using 4-0 chromic gut suture followed by skin closure using 9 mm stainless steel wound clips. Sham rats underwent identical surgery except that the ligatures were not tied around the nerve. Naïve control rats did not undergo any surgical procedures and are referred to as un-operated controls.

Figure 1. Chronic Constriction Injury (CCI) affects behavior, as well as mRNA and protein expression.

A. Sketch of the sciatic nerve with the chronic constriction injury sutures in place. B. Mechanical hyperentivity in the right hind paw. Bars represent the mean ± SEM normalized 50% withdrawal threshold from calibrated Semmes-Weinstein monofilaments (g) for each of the treatment groups; un-operated control (Con), sham-operated control (Sham), and chronic constriction injury (CCI). The more negative a mean difference score, the lower the pain threshold in the right hind paw. *Significant difference from un-operated control rats (Kruskal- Wallis 1-way ANOVA by ranks; P≤0.05). Un-operated and sham-operated control rats did not differ in normalized pain thresholds at day 8 or day 11 post-operative. Sample size representing each mean indicated on the graph. C. Relative Expression of mRNA assessed by qPCR (one step direct priming of mRNA). mRNA extracted from dissected L5 ipsilateral dorsal root ganglia for non-surgical control (Con), sham and CCI were used to compare the expression levels of TRPV1, Growth associated protein 43 (Gap43) and Neuropeptide Y (NPY). All three genes exhibit elevated levels of transcript expression in the CCI condition that were significantly different from control, indicating peripheral nerve trauma and neuropathic pain. For TRPV1, these data show that the CCI-treatment group was significantly different from the control groups (p<0.05). The CCI-treatment group was not significantly different from the sham group (p>0.05). For GAP43, these data show that the CCI-treatment group was significantly different from the control groups (p<0.05). The sham-treatment group was not significantly different from the control group (p>0.05). For NPY, these data show that the CCI-treatment group was significantly different from both the sham-treatment group and the control group (p<0.001). Sample size representing each mean indicated on the graph. D. DiD retrogradely labeled neurons from the right footpad of a CCI surgical animal. Cell bodies in the L5 doral root ganglia were processed for multi-stain confocal microscopy with anti-TRPV1 and anti-Neurofilament antibodies. The results reveal that some neurons co-label with TRPV1 and DiD, while other neurons identified with anti-Neurofilament antibody (*) lack both DiD and TRPV1. Scale Bar = 80 µm. E. Using Leica confocal software, the relative fluorescence of TRPV1 to DiD in co-expressing cells for representative CCI and comparably stained tissue sections from control DRG is shown. Sample size representing each mean indicated on the graph. TRPV1 protein expression is elevated in the CCI condition.

Behavioral Testing

On the day of surgery, prior to commencement of any surgical procedures, CCI, sham and control rats underwent baseline assessment for mechanical sensitivity. Behavioral testing was repeated on day 8 and day 11 post surgery. Following previously established methods, mechanical pain threshold was assessed by applying calibrated Semmes-Weinstein monofilaments to the plantar surface of both the left and right hind paw, specifically in the cutaneous region that is innervated exclusively by the sciatic nerve [32], [33].

A linear regression was used to estimate each rat’s 50% withdrawal threshold. As previously described [32], rats were placed on a metal grid and covered with a Plexiglas cover. The lowest-caliber filament (0.41 g) was pushed onto the plantar surface of the right hind paw 5 times until the filament bent; 2 to 3 seconds separated each push. Five minutes later, the left paw of the same rat was similarly assessed. Not less than 5 minutes after the left paw was assessed, the entire procedure was repeated. In this way, the right and left paws were probed with the 0.41 g filament 10 times, and the number of withdrawals was recorded. In ascending order, each filament was so tested until the rat withdrew from all 10 pushes of a single-sized filament or until the largest-caliber filament was tested.

To estimate the force from which the rat withdrew 50% of the time, force (in grams) was regressed on withdrawal frequency for all 5 filaments by using simple linear regression. The force at which the rat withdrew a paw on 5 of 10 pushes (50% withdrawal threshold) was predicted by using the regression equation. If the 50% withdrawal threshold so calculated was greater than 15.13 g, the highest-caliber filament used (15.13 g) was recorded as the gram force. If the rat failed to respond to any of the filaments, 15.13 g was recorded as the 50% withdrawal threshold. The same investigator always performed this test. Threshold levels were then expressed as a difference score between the pain threshold for the right and left hind paws. These values were normalized to differences that existed between the 2 paws at baseline. Statistics were performed using SPSS V12.0 software. We observed significant difference between the CCI condition and the un-operated control rats (Kruskal- Wallis 1-way ANOVA by ranks; P≤0.05). All behavioral testing was done by experimenter blinded to the surgical treatment. Rats used for the detailed behavioral testing consisted of a separate cohort from those used for the DRG analysis and in vivo imaging. All CCI animals were observed to exhibit guarding, paw licking and or paw lifting behaviors by day 8 post-surgery. However, only normal grooming behaviors were seen in the sham and un-operated controls.

Dorsal Root Ganglia Dissection

Nine days post surgery, bilateral L3, L4 and L5 DRG were dissected from CCI rats via laminectomy. These ganglia were chosen because neurons within them provide the sensory component of the sciatic nerve [34], [35]. Ganglia were rapidly removed and stored in RNAlater solution (Qiagen) for later use. Rats were sacrificed after completion of DRG extraction.

RNA Isolation and qPCR Analysis

Quantitative PCR (qPCR) and the comparative cycle threshold (CT) method [36] were used to determine if the CCI altered the mRNA expression of TRPV1, Neuropeptide Y (NPY) and Growth-associated Protein 43 (Gap43) relative to Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in L5 DRG 12 days post surgery (see Table S1 for primers). GAPDH, an important enzyme in glycolysis, serves as a control transcript for comparisons to transcripts from other genes expressed within the same tissue [37]. Tissue samples were removed from the RNAlater solution, processed over QiaShredder columns and RNA was extracted using the RNeasy kit (Qiagen, Valencia, CA). To prevent any genomic DNA contamination, each RNA sample was treated with DNase I (Invitrogen, Grand Island, NY).

Using RNA as the template, one step qPCR was performed with gene specific primers. Reverse-transcription was performed on the StepOnePlus machine using the Power SYBR Green RNA-to-CT 1-Step Kit (Applied Biosystems). RNA extracted from each rat was analyzed separately in triplicate. Analysis of amplified cDNA products by agarose gel and subsequent DNA sequencing confirmed the identity of the intended PCR product. All statistical tests were performed using SPSS software. Assumptions of ANOVA were met as indicated by Mauchly’s Test of Sphericity and Levine’s Test for Equality of Variances. Significance of the F statistic was defined as p≤0.05. TRPV1 mRNA levels in right (ipsilateral to the nerve injury) DRG of CCI rats was compared to right DRG of control (pooled) rats by performing a 1-Way ANOVA with treatment as the between-subjects factor.

Immunohistochemistry and Confocal Microscopy

Dorsal root ganglia from control and CCI rats, were used for immunohistochemistry to explore the protein expression levels of TRPV1. Under general anesthesia, prior to any surgical procedures, the CCI and control rats were injected with DiD Dye (V-22887, Invitrogen, Carlsbad, CA) in the plantar region of the right hindpaw. DiD is a lipophilic retrograde tracer that will stain all neuronal cells innervating the hindpaw. Post-treatment, all DRGs were removed and immediately fixed in 4% paraformaldehyde 1X Phosphate Buffer Saline (PBS) solution. The tissue samples were cryoprotected in 30% sucrose 1X PBS solution for 4 hours. After four hours of incubation, 1/3 of the cryoprotectant solution was replaced with Optimal Cutting Temperature (OCT) compound (Sakura-Finetek, Torrance, CA) and incubated on a rocking shaker overnight. After overnight incubation, samples were embedded in OCT and 20 µm thick sections were made on a cryostat. Sections were postfixed in 4% paraformaldehyde solution 1X PBS, permeabilized with 0.3% Triton X-100 solution and stained with primary and secondary antibodies. The following primary antibodies were used: 1∶50 mouse anti-rat Neurofilament-M (Neuromics, Edina, MN), 1∶50 rabbit anti-rat TRPV1 (Santa Cruz Biotechnology, Dallas, TX). The sections were then washed and incubated overnight with anti-mouse secondary antibodies conjugated to Alexa-546 (Invitrogen, Carlsbad, CA), and anti-rabbit-FITC (Santa Cruz Biotechnology, Dallas, TX), diluted 1∶100 in PBS. Sections were washed in 1X PBS and mounted in Prolong-Gold (Invitrogen, Carlsbad, CA). Relative expression of TRPV1 was determined by comparing the fluorescence intensity for TRPV1 to the fluorescence intensity of DiD, whose fluorescence intensity is not affected by the CCI surgery. This was done for labeled neurons from naïve control DRG and CCI DRG using the Leica TCS SP2 software version 2.3. For a double-labeled cell, the overall TRPV1 mean amplitude was divided by the overall mean DiD amplitude. The results of an unpaired t-test showed t = −6.45, sdev = 0.758E-01 degrees of freedom = 6. The probability of this result, assuming the null hypothesis, is 0.0007. An experimenter blind to treatment did staining and quantification of immunohistochemistry.

In separate immunohistochemical experiments using comparable protocols, the recovered control, sham and CCI sciatic nerves were prepared for examination using mouse anti rat CD68 antibody (MCA341R, AbD Serotech, Raleigh, NC) and Alexa fluor 488 donkey anti mouse secondary antibody (A-21202, Invitrogen, Carlsbad, CA) to assess the presence of macrophages that infiltrate the nerve.

Cellular uptake of nanoemulsion was performed in the mouse leukemic monocyte macrophage cell line RAW 264.7 (ATCC, Manassas VA) as described by Patel et al [38]. Approximately, 0.3 million cells were seeded on cover slips in 6-well plates in 2 mL culture medium per well and grown as adherent macrophages. After 48 h incubation at 37°C and 5% CO2, medium was aspirated and cells washed with 1X PBS. Cells were exposed to 2 mL of either fresh culture medium alone or dispersed nanoemulsion containing medium (10 µL/mL). Following 5 h incubation, 1 mL medium was aspirated and cells fixed with 1 mL 4% paraformaldehyde in 1X PBS. After 30 minutes at room temperature, the cells were washed with 1X PBS three times. Each coverslip with and without nanoemulsion labeled cells was transferred to glass slides containing a drop of ProLong Gold mounting medium. The nanoemulsion labeled with DiR (Invitrogen, Carlsbad, CA) was detected with 633 nm laser excitation and emission window of 700 nm to 850 nm. Confocal microscopy was performed on a Leica SP2 spectral Laser Scanning Confocal microscope. A transmission DIC image was acquired with each confocal scan.

NIR Labeled PFPE Nanoemulsion

NIR labeled PFPE Nanoemulsion (V-Sense DM NIR) was produced and provided by Celsense Inc (Pittsburgh, PA, USA) and was used without further modifications. Previous studies have demonstrated that the nanoemulsion droplets are on the order of 180–200 nm in size [19].

Live Animal Imaging (NIR)

To follow the localization of emulsion labeled circulating monocytes (monocytes in the blood, macrophages in tissue), NIR imaging of the fluorescent label in live rats was performed on a LiCOR Pearl Impulse (LI-COR Biosciences, Lincoln, NE) small animal imaging system. For the live animal imaging, rats were fed purified chow (D10012G Research Diets, Inc. New Brunswick, NJ), which helps to reduce non-specific fluorescence in the abdominal and thoracic region of the animal caused by certain foods. Tail-vein injection of 300 µL of V-Sense DM nanoemulsion was performed 8 days after surgery under general anesthesia. Within minutes, the injected animals were imaged in the LiCOR imager to establish that the intravenous injection was successful and that the nanoemulsion was not leaking subcutaneously within the tail. On day 11 post surgery, maximum neuroinflammation was predicted based on previous results, and another set of NIR imaging was performed under general anesthesia (xylazine, 7 mg/kg/ketamine, 80 mg/kg) given intraperitoneally. Simultaneous image acquisition of white light (body view) and 785 nm excitation for 820 nm emission were merged and processed in the LiCOR Pearl Impulse Software (version 2.0) with linked look-up-tables (LUT). Relative fluorescence was measured from a region of the same size over the sciatic nerve for both left and right legs for the naïve, sham and CCI conditions. This involved identifying a region of interest (ROI) around the fluorescent signal evident in the CCI. That ROI perimeter was then copied to the other legs for a given experiment. In this way, nearly the same number of pixels of area for the signal is compared within a given paired experiment. The ROI images for each rat (Figure S1) and the tabulation of relative fluorescence from the LiCOR Pearl Impulse software (Table S2) are shown in Supporting Information. Prism software version 5.0 was used to perform analysis of variance (ANOVA) for the entire set of conditions revealing a p value<0.0001 (Table S3). Furthermore, a t-test specifically comparing the sham right leg to the CCI right leg reveals a p value<0.0001. Dissected sciatic nerves were similarly imaged for NIR fluorescence on a flatbed LiCOR Odyssey Infrared Imaging system. An experimenter blinded to experimental conditions did the analysis of NIR Pearl images.

MRI (1H & 19F) Methods

1H and 19F MRI was performed on rat legs using a Bruker Biospec Avance III 7-T/21-cm system (Bruker Biospin MRI, Billerica MA) and a 35-mm (1H/19F) double resonance birdcage coil (Rapid MR International, Columbus OH). Following perfusion fixation, dissected legs were placed in a 50 mL conical tube and positioned in the magnet. Following pilot scans, the anatomical images were collected using a RARE (Rapid Acquisition with Relaxation Enhancement) sequence with both axial and a double oblique (parallel to the femur/tibia plane) coronal views. The following acquisition parameters were used: TR/TE 4000/7 ms, RARE Factor = 8, NA = 4, 6×6 cm FOV, 256×256 matrix, 2-mm slice thickness, and 22 or 14 contiguous slices for axial or coronal views, respectively. 19F MRI was performed at 282 MHz with the same slice geometry and the following parameters: TR/TE 3000/7 ms, RARE Factor = 4, 6×6 cm FOV, 128×128 matrix, and NA = 256 or 384 for axial or coronal views, respectively. Since the resonance frequencies were centered precisely on the water and the perfluorocarbon resonances, 19F and 1H anatomical images were co-registered without additional image processing.

19F NMR spectra for the PFPE nanoemulsion in the dissected sciatic nerves were acquired following standard protocols with trifluoroacetic acid (TFA) as the internal standard [38]. Nerves were inserted into borosilicate NMR tubes (5 mm diameter) and spectra recorded (Bruker, 470 MHz). 19F NMR peak around −92.5 ppm corresponding to fluorine nuclei was measured with TFA (set at −76.0 ppm) as reference (Figure S2).


In this study, we demonstrate that CCI rats exhibit symptoms of mechanical hypersensitivity, which is a hallmark of chronic pain. We also show that dual mode PFPE nanoemulsion can be used to reveal the focal point of neuroinflammation by both NIR imaging and 19F MRI. Furthermore, we demonstrate that the NIR and 19F signal is arising from CD68 positive macrophage cells carrying the nanoemulsion that infiltrate the CCI injured nerve. Due to anatomical barriers for free nanoemulsion delivery to the site of injury and considering the supporting histological findings, the NIR and 19F MRI signal shown arise from infiltrating cells.

Figure 1B illustrates that in the CCI rat, mechanical hypersensitivity is evident 11 days post surgery. Guarding behavior and other behaviors that are indicators of increased sensitivity were evident in all CCI animals. We also demonstrate that under these conditions, the mRNA expression levels of TRPV1, NPY and Gap43 are elevated on day 12 post surgery (Figure 1C). For TRPV1, the mean fold change values for the CCI-treatment, sham-treatment, and control groups were 2.60±0.352, 2.06±0.30, and 1.11±0.18, respectively. These data show that the CCI-treatment group was significantly different from the control groups (p<0.05). The CCI-treatment group was not significantly different from the sham group (p>0.05). For GAP43, the mean fold-change values for the CCI-treatment, sham- treatment, and control groups were 2.42±0.32, 1.52±0.51, and 1.00±0.07, respectively. These data show that the CCI-treatment group was significantly different from the sham-treatment and control groups (p<0.05). The sham-treatment group was not significantly different from the control group (p>0.05). For NPY, the mean fold change values for the CCI-treatment, sham-treatment, and control groups of 64.20±33.79, 6.49±6.21, and 1.44±1.34, respectively. These data show that the CCI-treatment group was significantly different from both the sham-treatment group and the control group (p<0.001).

To demonstrate that the expression of the TRPV1 protein is similarly elevated in the L5 dorsal root ganglia of CCI animals as compared to control, we analyzed tissue sections with antibodies against TRPV1 and Neurofilament-M (a neuronal marker). Additionally, the plantar region of the right rear paw of each rat was injected with DiD, a retrograde fluorescent dye that identifies the neurons innervating that specific region of the foot. Not all large diameter neurons in the dorsal root ganglia were positive for the DiD retrograde tracer since only a discrete number of neurons reach that region of the footpad. However, several DiD positive neurons are found and of those, some co-express TRPV1 in both control and CCI tissue. In the control, the immunofluorescent ratio of TRPV1/DiD is 0.787 indicating that under these conditions the DiD signal is brighter than the TRPV1 signal. However, in the CCI the TRPV1/DiD ratio is 1.12 (Figure 1E), indicative of elevated TRPV1 protein expression in these neurons of the dorsal root ganglion.

Figure 2 reveals that after the intravenous injection of the NIR labeled PFPE nanoemulsion, CCI injured rats exhibits NIR fluorescence that is focally localized parallel to the thigh (Figure 2I) at 11 days post CCI. This is in contrast to the autofluorescence evident in sham (Figure 2F) and control (Figure 2C) in the thoracolumbar regions, which is similar to that seen prior to the nanoemulsion injection (Figure 2 A, D, G). In a separate experiment, the surgical wound was occasionally found to exhibit low-level NIR fluorescence (Figure 3 B,C). This indicated that there was some superficial inflammation at the surgical wound as compared to the deeper sciatic nerve signal, which exhibits more scattering along the length of the sciatic nerve (Figure 3 E,F). Using the Li-COR Pearl Impulse software version 2.0 image analysis tools, we identified regions of interest (ROI) over the affected sciatic nerve for the CCI, sham and control animals (Figure S1 and Table S2). By averaging the normalized fluorescence (total relative fluorescence/total area) of the right and left legs, we demonstrate in Figure 3 G, that the CCI fluorescence is significantly brighter than the controls. ANOVA analysis of the entire data set comparing the relative fluorescence detected in the naïve right and left legs, the sham right and left legs and the CCI right and left legs reveals a difference for the CCI affected right leg with a p value<0.0001 (Table S3). A t test specifically comparing the affected CCI right leg to the sham surgical right leg reveals a significant difference with a p value<0.0001 (Table S3). However, given that NIR imaging cannot unequivocally provide spatial localization of the fluorescence, we continued the analysis by assessing the fluorescence of the dissected sciatic nerve from the sham as compared to the CCI animal (Figure 3 H,I). With CCI and sham nerves lying side-by-side and imaged simultaneously on the flatbed Li-COR Odyssey imaging system, only the CCI shows positive signal.

Figure 2. Near Infrared imaging (NIR) of live rats merged with white light images of their body, 2 days post intravenous injection of labeled emulsion on day 11 post surgery.

All of these images were acquired on the LiCOR Pearl Live animal imager and processed in the same experiment with linked look-up tables. The control (A, B, C) and sham (D, E, F) exhibit only auto fluorescence over the thoracolumbar region, which is evident prior to injection (A, D, G). The inset in F exhibits a dorsal view of the wound, which lacks any fluorescent signal. The CCI affected right leg (I) exhibits a clear band of fluorescent signal aligned with the position of the sciatic nerve (arrow), which runs parallel to the femur. No signal is evident on the CCI animal’s unaffected left leg (H). Note – supplemental data (Figure S3) of a comparable experiment reveals only autofluoresence in sham and naïve controls, while only the CCI exhibits extensive signal along the length of the thigh, parallel to the position of the right sciatic nerve. Bar = 1 cm.

Figure 3. Near Infrared imaging (NIR) of live rats merged with white light images of their body, 2 days post intravenous injection of labeled emulsion on day 11 post surgery compared to day 18 post surgery.

All of these images were acquired on the LiCOR Pearl Live animal imager and processed in the same experiment with linked look-up tables. Bar = 1 cm. The sham surgical control (A, B, C) exhibits auto fluorescence over the thoracolumbar region, which is also evident prior to injection. In the sham animal, a superficial fluorescence signal is detected precisely on the surgical wound. That surgical wound signal is dramatically reduced by day 18 (C) in the same sham animal. The CCI experimental animal (D, E, F) exhibits auto fluorescence over the thoracolumbar region, which is also evident prior to injection. The CCI affected right leg (E) exhibits a clear band of fluorescent signal aligned with the position of the sciatic nerve (black arrow) along the entire length of the thigh. No signal is evident on the CCI animal’s unaffected left leg (D). On day 18, the signal in the Sham attributed to the wound has nearly completely resolved and no signal is apparent along the sciatic nerve (C). The CCI sciatic nerve associated signal persists in at day 18 (F). Bar = 1 cm. G. The relative fluorescence of a region over the sciatic nerve is compared. For each condition ROI measurements were made (Figure S1, Table S2) for the 4 sets of data giving a sample number of 4 to 5. The results of the ANOVA test (Table S3) show that the relative fluorescence in the CCI right is significantly different from the remainder of the samples with a p value<0.0001. Separately, a t-test analysis of the Sham right versus the CCI right revealed a p value of <0.0001. Sciatic nerve dissected from comparable animals imaged simultaneously in the same field of view for NIR fluorescence on the LiCOR Odessey Flatbed Imager (H, I). The CCI sciatic nerve (I) exhibits a strong fluorescent signal in comparison to the sham sciatic nerve (H).

In preparation of the MRI analysis of the tissues, we assessed the NMR spectra of the dissected sciatic nerves to ascertain that the only fluorine signature to be detected was arising from the nanoemulsion and not any contribution that may come from natural sources or from anesthesia. The NMR spectra (Figure S2) show that the only detectable fluorine in the sciatic nerve arises from the PFPE nanoemulsion.

Analysis of the same right legs as those shown in Figure 2F for the Sham and Figure 2I for the CCI condition by proton and 19F MRI show that the PFPE signal is coincident with the ligation of the sciatic nerve (Figure 4). Figure 4A shows that the four suture knots associated with the constriction injury are visible by proton MRI along the sciatic nerve, which is running parallel to the femur. The sciatic nerve (white arrow inset), tibia (T) and femur (F) are clearly visible in the adjacent image slice (Figure 4A – inset). Fluorine signal is evident along the sciatic nerve in the region of the sutures (Figure 4B) as well as in the bone marrow of the proximal head of the tibia. Viewed in cross section (Figure 4B – inset), 19F signal is evident in the sciatic nerve, the femur as well as a slight signal where some minor inflammation persists at the site of the surgical wound. The clips had been removed on day 7 post-surgery. In the sham, a lower level of 19F signal is evident only in the bone marrow near the head of the femur (Figure 4C). A comparable experiment revealed PFPE nanoemulsion labeled inflammation in the region of the CCI sciatic nerve (Figure S3C) as compared to control and sham.

Figure 4. 1H and 19F MRI of the hind limbs for the rats shown in Figure 2F and 2I.

Panel A shows an anatomical (1H) image of the leg for the animal shown in 2I. The black arrow indicates the sutures used for the chronic constriction injury. The long white arrows indicate the position of the tibia, fibula and femur. The inset image shows the adjacent image slice, giving a clearer view of the tibia (T) and the femur (F). The white arrow in inset panel A points to the sciatic nerve, which appears as a white line. Panel B shows a composite 1H/19F image. The 19F image is rendered in pseudo color (red) and is overlaid on the anatomical image shown in A. A significant amount of 19F signal is observed at the sutured sciatic nerve. A small amount of fluorine signal is also evident at the head of the tibia and slight in the femur. The inset shows an axial view of the thigh revealing the femur in cross section. A small amount of fluorine signal is observed at the surface aligning with the surgical wound, where minor superficial inflammation is still evident (arrow head). The (F) indicates the femur in cross sections with a low level of 19F signal. The white arrow indicates the sciatic nerve with 19F signal. The asterisk (*) is near the femoral artery. Panel C shows a 1H/19F composite image of the sham right leg from the animal shown in Figure 2F. No fluorine signal was observed at the sciatic nerve, however a weak signal was observed in the femur, presumably in the bone marrow (arrow). The inset shows an axial view at the level of the arrow near the head of the femur (F) with 19F signal in the bone marrow. The black arrow points to the femur and the asterisk (*) is near the femoral artery. Bar = 1 cm.

To confirm that the PFPE signal is localized to the site of neuroinflammation byinfiltration of macrophages into the actual nerve, we sectioned the recovered sciatic nerve from the CCI right leg and the left leg of the same animal shown in Figure 2H, I and Figure 4A, B and stained the nerve with anti-CD68 antibody (Figure 5A–D). Similarly, the sciatic nerves from the un-operated control and the sham were also recovered for analysis (Figure 5 G–J). The results clearly demonstrate that macrophages have infiltrated into the CCI nerve, but not any of the controls. In duplicate experiments, examination of the macrophages revealed that they exhibit granular cytoplasm (Figure 5E, F). The nanoemulsion droplets in these cells are consistent with the nature of nanoemulsion droplets detected in macrophages grown in cell culture, which measure at the limit of spatial resolution for the light microscope with a size of 200–300 nm (Figure 5 K, L, M, N), which is consistent with the analytic size measurement of 180–200 nm in diameter [19].

Figure 5. Cryosection of sciatic nerve.

A,B show the affected right sciatic nerve from the CCI leg shown in Figure 2I stained with anti-CD68 antibody to reveal the presence of macrophages infiltrating the nerve. C, D CD68 positive cells are not present in the left leg (contralateral to surgery Figure 2H) of the same CCI animal. E,F show a nerve from a separate CCI animal that also exhibits infiltration of CD68 positive cells. The boxed area is enlarged to reveal the granular cytoplasm (black arrow) of the macrophages, indicative of the presence of the nanoemulsion. Sham surgical sciatic nerve and non-surgical control sciatic nerve do not exhibit any CD68 positive cells (G,H) and (I,J). The fluorescent images A, C, G, and I were all acquired at the same sitting with the exact same image acquisition parameters. Macrophages grown in cell culture take up the nanoemulsion, exhibited as particles evident by both confocal fluorescence emissions 700–850 nm of NIR label (DiR) (K, M) as well as transmitted light (L, N).


Here we report the first live imaging of neuroinflamation in the CCI neuropathic pain model with NIR and 19F labeled nanoemulsion taken up by circulating monocytes that infiltrate into the damaged sciatic nerve and present as macrophages.

Chronic neuropathy in the CCI rat model leads to mechanical hypersensitivity [39]. Figure 1B demonstrates significant induction of mechanical hypersensitivity in ipsilateral hindpaw of CCI rat. We note that the role of TRPV1 as a nociceptor has been widely documented in a variety of acute, chronic, and neuropathic pain models and diseases such as diabetic neuropathy, chronic pancreatitis, cancer pain, osteoarthiritis, and gastrointestinal diseases [40], [41], [42], [43]. NPY is a peptide neurotransmitter released by primary afferent neurons located in the dorsal root ganglia and received by neurons located in the substantia gelatinosa region of the spinal cord [44]. In animal models of neuropathic pain, NPY has been shown to be upregulated [45], [46], and can be used as an indicator that trauma to the nerve has occurred. During development, Gap43 is a growth-associated protein that is highly expressed in the growth cones of elongating axons. Its expression decreases after the target has been innervated [47]. In addition to its developmental role, Gap43 is also differently expressed following neuronal tissue damage or inflammation, which has been demonstrated in several animal neuropathy models [47], [48], [49] and can be used to verify that trauma has occurred in peripheral nerve tissue.

We have demonstrated that in the CCI pain model, changes in mRNA expression levels of TRPV1 as well as NPY and Gap43 are evident in lumbar level five dorsal root ganglia using one-step qPCR analysis (Figure 1C). TRPV1 is known to play a role in inflammatory as well as neuropathic pain models [50]. The increased expression of NPY, a neurotransmitter, is known to play a role in modulating both innate and adaptive immune response [51], including modulating the phagocytic uptake by neutrophils and macrophages [52]. Furthermore, NPY has been shown to modulate neuronal signaling in acute pain, neuropathic pain and inflammatory animal pain models and induces anti-nociceptive effects [44]. The increase in NPY expression provides indirect evidence to support the interpretation that nerve trauma has been induced on the sciatic nerve. We find that mRNA expression of TRPV1 was increased in the ipsilateral dorsal root ganglia level 5 as compared to the control rat (Figure 1C). Furthermore, neurons in the dorsal root ganglia that are retrograde labeled with DiD from the plantar foot pad injection exhibit a relative increase in TRPV1 protein expression in the CCI condition as compared to un-operated control rats (Figure 1D, E). Collectively, these results demonstrate that CCI is inducing a hypersensitivity associated with changes in gene expression for the nerves of the affected DRG and sciatic nerve.

We also reported the in vivo imaging of neuroinflammation in the CCI sciatic nerve using dual mode (NIR and 19F MRI) nanoemulsion. Both resident and hematogenous immune cells are involved in causing neuroinflammation at the site of injury in CCI rat model [18]. The infiltration of immune cells into the site of injury results in the release of inflammatory mediators, which then cause changes in the gene expression profile of the affected neurons and leads to peripheral sensitization [53]. In vivo imaging of granulomatous inflammation has been previously reported via labeling of macrophages with fluorescent NIR dye [54]. However, optical imaging is compromised due to the absorption and scattering of both the excitation and emitted light [55]. 19F MRI has an advantage in that it is not limited by depth and has no background noise in tissues [56]. 19F MRI has also been successfully used for in vivo imaging and quantification of inflammation in various animal disease models [20], [31], [57]. Previously, we demonstrated in vitro phagocytic uptake of a dual labeled nanoemulsion by macrophages in culture [38]. Here, we again demonstrate that a perfluorocarbon nanoemulsion containing both NIR dye and 19F [19] is taken up by macrophages in culture as an assessment of toxicity and uptake as previously measured [19], [38], which gave us confidence that we could achieve adequate sensitivity in vivo by both imaging modalities (Figure 5 K–N). This nanoemulsion is then used in order that we might achieve maximum sensitivity and specificity in vivo, in the analysis of neuroinflammation in CCI.

On day 8 post surgery, an intravenous injection of the nanoemulsion was given to the rats followed immediately by NIR fluorescence assessment to ensure that the injection was not inadvertently released subcutaneously. In the bloodstream, the phagocytic cells evidently engulf these nanoemulsion droplets through a still undetermined mechanism. These labeled immune cells naturally migrate to the site of injury to participate in the inflammatory response. NIR fluorescence emission from the labeling was observed only on the ipsilateral side of the CCI rat overlying the site of sciatic nerve ligation (Figure 2I and Figure 3E, F, I). Fluorescence was absent on hind limbs of sham rat, control rat and the contralateral hind limb of CCI rat (Figure 2 B, C, E, F, Hand Figure 3 A–D). NIR imaging was used to reveal the accumulation of immune cells at the site of sciatic nerve injury in live animals. Macrophages are the primary immune cells that phagocytose perfluorocarbon nanoemulsion droplets and they represent the majority of all the labeled cells [20]. The results from our in vivo NIR imaging suggest that the fluorescence signal is associated with neuroinflammation at the site of sciatic nerve injury in CCI rats. To confirm that the observed fluorescence originated in the sciatic nerve, ex vivo NIR imaging of the recovered injured sciatic nerves was performed. Fluorescence emission for NIR dye was observed only in the CCI ipsilateral sciatic nerve and not the ipsilateral nerve of the sham animal (Figure 3 H,I). The results complement the findings from the in vivo imaging and show that a fluorescence signal is present in the dissected nerve from the CCI rat, which is indicative of the accumulation of labeled macrophages.

To confirm that the fluorescence signal at the site of CCI injury was due to accumulation of nanoemulsion labeled macrophages, highly sensitive19F NMR spectroscopy and 19F MRI were performed. NMR spectroscopy (Figure S2) demonstrates that in the dissected sciatic nerve, the only fluorine signature arises from the 19F in the PFPE.

The 19F signal localizes at the site of sciatic nerve injury in the CCI rats and no such signal was observed in the sham rat (Figure 4). The presence of 19F signal was also observed in the femur and tibia of CCI and sham rats. Complex regional pain syndrome has previously been associated with osteoporotic changes in human subjects [58]. Furthermore, it has been demonstrated that osteoporotic changes in the ipsilateral tibial bone occur after CCI surgery. These changes are also associated with an increased number of osteoclasts in the bone [59]. Hence, the 19F signal we observed in the bone marrow (Figure 4) could be indicative of the osteoporotic changes in the femur and tibia of CCI rats and is a result of the peripheral nerve injury. It has also been shown that a subset of blood monocytes could serve as osteoclast precursors [60]. Overall, our interpretation is that the 19F signal evident in the bone marrow is due to migration of labeled monocytes to the bone.

Immunohistochemistry performed on the ipsilateral sciatic nerve of CCI rat clearly demonstrates infiltration of macrophages in the sciatic nerve (Figure 5). No such infiltration was observed for the left leg contralateral to the CCI, the ipsilateral sham and the control nerves (Figure 5). Therefore, the 19F signal and the fluorescence observed during in vivo and ex vivo NIR imaging is due to infiltration of labeled macrophages at the site of injury.


This study demonstrates that the infiltration of immune cells into the CCI affected sciatic nerve can be monitored in live animals. Furthermore, the neuroinflammation caused by the CCI surgery can be imaged using the dual mode nanoemulsion such that both live animal NIR imaging and post-mortem perfluorocarbon 19F MRI generate complementary results demonstrating that this neuroinflammation contributes to the pain associated with CCI surgery. In rats, specifically targeting the immune cells in vivo may serve as a treatment for neuroinflammation. The same technique could be used to monitor the effect of therapeutic drugs by assessing the extent of inflammation at the site of injury and to diagnose neuroinflammation without the need for surgical intervention involving a nerve biopsy.

Supporting Information

Figure S1.

Near Infrared imaging (NIR) of live rats merged with white light images with the Region of Interest (ROI) indicated. All of these images were acquired on the LiCOR Pearl Live animal imager and processed in the same linked look-up tables. The ROI was set for the right leg CCI condition and then copied to a similar relative position on each of other legs for that experimental set. The LiCOR software tabulates the relative fluorescent signal and area (note Table S2).


Figure S2.

19F NMR spectra for nanoemulsion in dissected CCI sciatic nerve. Exhibits 19F NMR spectrum of dissected right sciatic nerve from CCI animal. TFA (−76.00 ppm) reference standard is shown along with the tissue signal for the nanoemulsion in the sciatic nerve (−92.5 ppm).


Figure S3.

Near Infrared imaging (NIR) of live rats merged with white light images of their body, 2 days post intravenous injection of labeled emulsion on day 11 post surgery. All of these images were acquired on the LiCOR Pearl Live animal imager and processed in the same experiment with linked look-up tables. The control, sham and CCI (A–F) exhibit auto fluorescence over the thoracolumbar region, which is also evident prior to injection (Note Figure 2). The control animal (A) does not exhibit any fluorescence over the right leg. The sham (B) similarly does not exhibit any fluorescence in the area of the surgical wound (surgical staples). The CCI animal (C) exhibits a wide area of fluorescent signal over much of the thigh. The left side of the control, sham and CCI (D, E, F) exhibit only the auto fluorescence in the thoracolumbar region. Bar = 1 cm.


Table S1.

Primer Sequences used for this study.


Table S2.

LiCOR total relative fluorescence for each ROI. The Mean (Total Relative Fluorescence/Area) for each ROI is used for the analysis of variance (ANOVA) and t-test.


Table S3.

1 Way ANOVA of Relative NIR Fluorescence in Live Rats.



The authors acknowledge the immunofluorescence contribution of Sophia Williard (BIOL 372 Cell & Systems Physiology course – J.A. Pollock Professor) and members of BIOL 376 Microscopy course (J.A. Pollock Professor). Robert Hoggard provided artwork and Prof. David L. Somers (Rangos School of Health Sciences, Duquesne University) provided assistance with CCI surgery training. 19F NMR analyses performed at Pittsburgh NMR Center for Biomedical Research (Carnegie Mellon University) and at the Center for Molecular Analysis (Carnegie Mellon University).

Author Contributions

Conceived and designed the experiments: KV JMJ JAP. Performed the experiments: KV KA BZ-J SKP TKH JAP. Analyzed the data: KV KA BZ-J SKP TKH JMJ JAP. Contributed reagents/materials/analysis tools: AB TKH JMJ JAP. Wrote the paper: KV JMJ JAP.


  1. 1. von Hehn CA, Baron R, Woolf CJ (2012) Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron (73): 638–652.
  2. 2. Jensen TS, Baron R, Haanpää M, Kalso E, Loeser JD, et al. (2011) A new definition of neuropathic pain. Pain 152: 2204–2205.
  3. 3. National Research Council. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington, DC: The National Academies Press, 2011.
  4. 4. Tal M (1999) A role for inflammation in chronic pain. Curr Rev Pain 3(6): 440–446.
  5. 5. Bennett GJ, Xie YK (1998) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33: 87–107.
  6. 6. Wang LX, Wang ZJ (2003) Animal and cellular models of chronic pain. Adv Drug Deliv Rev 55(8): 949–965.
  7. 7. Stanton-Hicks M, Jänig W, Hassenbusch S, Hqddox JD, Boas R, et al. (1995) Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain 63(1): 127–133.
  8. 8. Baron R, Wasner G (2001) Complex regional pain syndromes. Curr Pain Headache Rep 5: 114–123.
  9. 9. Woolf CJ, Ma Q (2007) Nociceptors–noxious stimulus detectors. Neuron 55: 353–364.
  10. 10. Montell C (2005) The TRP superfamily of cation channels. Sci STKE 2005: re3.
  11. 11. Voets T, Talavera K, Owsianik G, Nilius B (2005) Sensing with TRP channels. Nat Chem Biol 1: 85–92.
  12. 12. Damann N, Voets T, Nilius B (2008) TRPs in our senses. Curr Biol 18: R880–R889.
  13. 13. Cortright DN, Szallasi A (2009) TRP channels and pain. Curr Pharm Des 15: 1736–1749.
  14. 14. Stucky CL, Dubin AE, Jeske NA, Malin SA, McKemy DD, et al. (2009) Roles of transient receptor potential channels in pain. Brain Res Rev 60: 2–23.
  15. 15. Clatworthy AL, Illich PA, Castro GA, Walters ET (1995) Role of peri-axonal inflammation in the development of thermal hyperalgesia and guarding behavior in a rat model of neuropathic pain. Neurosci Lett 184: 5–8.
  16. 16. Thacker MA, Clark AK, Marchand F, McMahon SB (2007) Pathophysiology of peripheral neuropathic pain: Immune cells and molecules. Anesthesia and Analgesia 105: 838–847.
  17. 17. Myers RR, Heckman HM, Rodriguez M (1996) Reduced hyperalgesia in nerve-injured WLD mice: relationship to nerve fiber phagocytosis, axonal degeneration, and regeneration in normal mice. Exp Neurol 141: 94–101.
  18. 18. Gaudet AD, Popovich PG, Ramer MS (2011) Wallerian degeneration: Gaining perspective on inflammatory events after peripheral nerve injury, Journal of Neuroinflammation. 8: 110.
  19. 19. Balducci A, Wen Y, Zhang Y, Helfer BM, Hitchens TK, et al. (2013) A novel probe for the non-invasive detection of tumor-associated inflammation. OncoImmunology 2: e23034.
  20. 20. Ahrens ET, Young WB, Xu H, Pusateri LK (2011) Rapid quantification of inflammation in tissue samples using perfluorocarbon emulsion and fluorine-19 nuclear magnetic resonance. Biotechniques 50(4): 229–234.
  21. 21. Srinivas M, Morel PA, Ernst LA, Laidlaw DH, Ahrens ET (2007) Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model. Magn Reson Med 58(4): 725–734.
  22. 22. Srinivas M, Turner MS, Janjic JM, Morel PA, Laidlaw DH, et al. (2009) In vivo cytometry of antigen specific T-cells using 19F MRI. Magnetic Resonance in Medicine 62: 747–753.
  23. 23. Boehm-Sturm P, Mengler L, Wecker S, Hoehn M, Kallur T (2011) In vivo tracking of human neural stem cells with (19)F magnetic resonance imaging. PLoS ONE 6(12): e29040.
  24. 24. Temme S, Bönner F, Schrader J, Flögel U (2012) 19F magnetic resonance imaging of endogenous macrophages in inflammation. WIREs Nanomed Nanobiotechnol 4: 329–343.
  25. 25. Janjic JM, Ahrens ET (2009) Fluorine-containing nanoemulsions for MRI cell tracking. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1(5): 492–501.
  26. 26. Chen J, Lanza GM, Wickline SA (2010) Quantitative magnetic resonance fluorine imaging: today and tomorrow. WIREs Nanomed Nanobiotechnol 2: 431–440.
  27. 27. Hu P, McLachlan EM (2002) Macrophage and lymphocyte invasion of dorsal root ganglia after peripheral nerve lesions in the rat. Neuroscience 112 (1): 23–38.
  28. 28. Ma W, Quirion R (2005) Up-regulation of interleukin 6 induced by prostaglandin E2 from invading macrophages following nerve in- jury: an in vivo and in vitro study. J. Neurochem 93: 664–673.
  29. 29. Morin N, Owolabi SA, Hartyetal MW (2007) Neutrophils invade lumbar dorsal root ganglia after chronic constriction injury of the sciatic nerve. Journal of Neuroimmunology 184 (1–2): 164–171.
  30. 30. Di Cesare Mannelli L, D’Agostino G, Pacini A, Russo R, Zanardelli M, et al.. (2013) Palmitoylethanolamide Is a Disease-Modifying Agent in Peripheral Neuropathy: Pain Relief and Neuroprotection Share a PPAR-Alpha-Mediated Mechanism. Mediators of Inflammation Volume 2013, Article ID 328797. Available:
  31. 31. Weise G, Basse-Luesebrink TC, Wessig C, Jakob PM, Stoll G (2011) In vivo imaging of inflammation in the peripheral nervous system by 19F MRI, Experimental Neurology. 229: 494–501.
  32. 32. Somers DL, Clemente FR (2003) The relationship between dorsal horn neurotransmitter content and allodynia in neuropathic rats treated with high- frequency transcutaneous electric nerve stimulation. Archives of Physical Medicine and Rehabilitation (84): 1575–1583.
  33. 33. Swett JE, Woolf CJ (1985) The somatotopic organization of primary afferent terminals in the superficial laminae of the dorsal horn of the rat spinal cord. Journal of Comparative Neurology 231(1): 66–77.
  34. 34. Swett JE, Torigoe Y, Elie VR, Bourassa CM, Miller PG (1991) Sensory neurons of the rat sciatic nerve. Experimental Neurololgy 114: 82–103.
  35. 35. Ji RR, Samad TA, Jin SX, Schmoll R, Woolf CJ (2002) p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 36: 57–68.
  36. 36. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (4): 402–408.
  37. 37. Barber RD, Harmer DW, Coleman RA, Clark BJ (2005) GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues, Physiological Genomics. 3: 389–395.
  38. 38. Patel SK, Zhang Y, Pollock JA, Janjic JM (2013) Cyclooxgenase-2 Inhibiting Perfluoropoly (Ethylene Glycol) Ether Theranostic Nanoemulsions–In Vitro Study. PloS One 8 (2): e55802.
  39. 39. Field MJ, Bramwell S, Hughes J, Singh L (1999) Detection of static and dynamic components of mechanical allodynia in rat models of neuropathic pain: are they signaled by distinct primary sensory neurons? Pain 83: 303–311.
  40. 40. Hong S, Agresta L, Guo C, Wiley JW (2008) The TRPV1 receptor is associated with preferential stress in large dorsal root ganglion neurons in early diabetic sensory neuropathy. J Neurochem 105: 1212–1222.
  41. 41. Xu GY, Winston JH, Shenoy M, Yin H, Pendyala S, Pasricha PJ (2007) Transient receptor potential vanilloid 1 mediates hyperalgesia and is up-regulated in rats with chronic pancreatitis. Gastroenterology 133(4), 1282–1292.
  42. 42. Szabó A, Helyes Z, Sándor K, Bite A, Pintér E, et al.. (2005) Role of transient receptor potential vanilloid 1 receptors in adjuvant-induced chronic arthritis: in vivo study using gene-deficient mice. J Pharmacol Exp Ther 314, 111–119.
  43. 43. Jones RC, Xu L, Gebhart GF (2005) The mechanosensitivity of mouse colon afferent fibers and their sensitization by inflammatory mediators require transient receptor potential vanilloid 1 and acid-sensing ion channel 3. J Neurosci 25: 10981–10989.
  44. 44. Smith PA, Moran TD, Abdulla F, Tumber KK, Taylor BK (2007) Spinal mechanisms of NPY analgesia. Peptides 28(2): 464–474.
  45. 45. Moran TD, Colmers WF, Smith PA (2004) Opioid-like actions of neuropeptide Y in rat substantia gelatinosa: Y1 suppression of inhibition and Y2 suppression of excitation. J Neurophysiol 92: 3266–3275.
  46. 46. Staaf S, Oerther S, Lucas G, Mattsson JP, Ernfors P (2009) Differential regulation of TRP channels in a rat model of neuropathic pain. Pain 144(1–2), 187–199.
  47. 47. Leslie TA, Emson PC, Dowd PM, Woolf CJ (1995) Nerve growth factor contributes to the up-regulation of growth-associated protein 43 and preprotachykinin A messenger RNAs in primary sensory neurons following peripheral inflammation. Neuroscience 67: 753–761.
  48. 48. Van der Zee CE, Nielander HB, Vos JP, Lopes da Silva S, Verhaagen J, et al. (1989) Expression of growth-associated protein B-50 (GAP43) in dorsal root ganglia and sciatic nerve during regenerative sprouting. J Neurosci 9(10): 3505–3512.
  49. 49. Andersen LB, Schreyer DJ (1999) Constitutive expression of GAP-43 correlates with rapid, but not slow regrowth of injured dorsal root axons in the adult rat. Exp Neurol 155: 157–164
  50. 50. Kanai Y, Nakazato E, Fujiuchi A, Hara T, Imai A (2005) Involvement of an increased spinal TRPV1 sensitization through its up-regulation in mechanical allodynia of CCI rats. Neuropharmacology 49: 977–984.
  51. 51. Wheway J, Herzog H, Mackay F (2007) The Y1 receptor for NPY: A key modulator of the adaptive immune system. Peptides 28: 453–458.
  52. 52. Bedoui S, von Horsten S, Gebhardt T (2007) A role for neuropeptide Y (NPY) in phagocytosis: Implications for innate and adaptive immunity. Peptides 28: 373–376.
  53. 53. Ren K, Dubner R (2010) Interactions between the immune and nervous systems in pain. Nature Medicine 16 (11): 1267–1276.
  54. 54. Eisenblatter M, Ehrchen J, Varga G, Sunderkotter C, Heindel W, et al. (2009) In Vivo Optical Imaging of Cellular Inflammatory Response in Granuloma Formation Using Fluorescence-Labeled Macrophages, The Journal of Nuclear Medicine 50. (10): 1676–1682.
  55. 55. Mayer-Kuckuk P, Boskey AL (2006) Molecular imaging promotes progress in orthopedic research. Bone 39: 965–977.
  56. 56. Srinivas M, Heerschap A, Ahrens ET, Figdor CG, de Vries JM (2010) 19F MRI for quantitative in vivo cell tracking, Trends in Biotechnology. 28(7): 363–370.
  57. 57. Kadayakkara DK, Ranganathan S, Young W, Ahrens ET (2012) Assaying macrophage activity in a murine model of inflammatory bowel disease using fluorine-19 MRI. Laboratory Investigation 92: 636–645.
  58. 58. Moriwaki K, Yuge O, Tanaka H, Sasaki H, Izumi H, Kaneko K (1997) Neuropathic pain and prolonged regional inflammation as two distinct symptomatological components in complex regional pain syndrome with patchy osteoporosis – a pilot study. Pain 72: 277–282.
  59. 59. Suyama H, Moriwaki K, Niida S, Maehara Y, Kawamoto M, Yuge O (2002) Osteoporosis following chronic constriction injury of sciatic nerve in rats, Journal of Bone and Mineral Metabolism. 20: 91–97.
  60. 60. Lari R, Kitchener PD, Hamilton JA (2009) The proliferative human monocyte subpopulation contains osteoclast precursors. Arthritis Research and Therapy 11(1): R23.